Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Prognostic implication of gait function following treatment for spinal cord compression in men diagnosed with prostate cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Educational level and first-time PSA testing in general practice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Robotic versus laparoscopic urological surgery: incidence of reoperation and complications

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. A case of xanthogranulomatous inflammation of the urethra treatment with a steroid-based non-surgical approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Human papillomavirus and squamous cell carcinoma of the urinary bladder: DaBlaCa-10 study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Malignant spinal cord compression (MSCC) is a severe complication of metastatic prostate cancer (PCa) and may compromise neurological functions, including gait function. This study aimed to evaluate the association between survival and gait function prior to, immediately after and 6 weeks following radiotherapy for MSCC in PCa patients. Patient sample: All PCa patients admitted with MSCC at Rigshospitalet, Denmark from January 1, 2010 to December 31, 2011 were included. Patients were followed until death to analyze gait function as a prognostic factor. Methods: Of the 76 included patients, four patients underwent surgical decompression followed by radiotherapy and 72 patients received only radiotherapy. Gait was evaluated prior to radiotherapy, immediately after radiotherapy and at 6 weeks follow-up. Results: Before radiotherapy, 88% had normal gait function and 12% had complete loss of gait function. Corresponding percentages after radiotherapy were 72% and 28%, respectively. Median overall survival following MSCC was 4.9 months (95% CI = 3.6-6.2) with a 3-, 6-, and 12-months survival probability of 64%, 42%, and 21%, respectively. Multivariate analyses demonstrated that patients without gait function after radiotherapy had a 2.6-2.8-fold increased risk of dying compared to men with gait function. Patients with more than two vertebrae involved had a 2.3-3.4-fold increased risk of dying when compared to patients with 1-2 vertebral metastases. Conclusions: PCa patients with MSCC have a poor prognosis. Most likely reflecting differences in tumor burden, preserved gait function following radiotherapy is associated with better prognosis. Further prospective studies are required to confirm this association.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Urology
Vol/bind53
Udgave nummer4
Sider (fra-til)222-228
Antal sider7
ISSN2168-1805
DOI
StatusUdgivet - 2019

ID: 58147738